Ghost Tree Capital »

Perspective Therapeutics shares owned by Ghost Tree Capital

Quarter-by-quarter ownership of Perspective Therapeutics (CATX) shares owned by Ghost Tree Capital from 13F filings

Historical chart of Ghost Tree Capital investment in Perspective Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Perspective Therapeutics held by Ghost Tree Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perspective Therapeutics by Ghost Tree Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $9.2M 925k 9.97

More positions owned by Ghost Tree Capital

Alnylam Pharmaceuticals (ALNY)
Insmed Com Par $.01 (INSM)
Biohaven (BHVN)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Soleno Therapeutics (SLNO)
Axsome Therapeutics (AXSM)
Ascendis Pharma A/s Sponsored Adr (ASND)
Vaxcyte (PCVX)
Crinetics Pharmaceuticals In (CRNX)
Roivant Sciences SHS (ROIV)
Perspective Therapeutics Com New (CATX)
Tg Therapeutics (TGTX)
Sarepta Therapeutics (SRPT)
Cg Oncology (CGON)
Corbus Pharmaceuticals Hldgs Com New (CRBP)

View all positions for Ghost Tree Capital

Top funds holding Perspective Therapeutics

Henderson Group
BlackRock
BlackRock
Avidity Partners Management
Commodore Capital
Vanguard Group
Deerfield Management Company
Nicholson Wealth Management Group
Marshall Wace
Octagon Capital Advisors
Geode Capital Management
Hills Bank And Trust Company
State Street Corporation
Ghost Tree Capital
Paradigm Biocapital Advisors

View all funds holding Perspective Therapeutics